Lamattina John L

Ligand Pharmaceuticals Inc.

Director

Avg. Two Year Performance

134% Avg. Purchase Return 53% Compound

27% Avg. Sale Return 13% Compound

Holdings: 28.26K shares

Last Three Months: 26-Aug-24 -- 25-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions